Cours Cocrystal Pharma Inc OTC Bulletin Board
Actions
US19188J1025
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 16,38 M 14,85 M |
---|---|---|---|---|---|
Résultat net 2024 * | -23 M -20,85 M | Résultat net 2025 * | -24 M -21,76 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-0,7
x | PER 2025 * |
-0,82
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 69,97% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Sam Lee
CEO | Chief Executive Officer | 64 | 02/01/14 |
James Martin
CEO | Chief Executive Officer | 58 | 23/02/17 |
Roger Kornberg
CHM | Chairman | 77 | 02/01/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Phillip Frost
BRD | Director/Board Member | 87 | 02/01/14 |
Director/Board Member | 68 | 27/05/21 | |
Steven Rubin
BRD | Director/Board Member | 63 | 02/01/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+9,15% | 106 Md | |
-1,08% | 104 Md | |
+6,43% | 23,25 Md | |
-11,55% | 22,5 Md | |
-7,19% | 18,7 Md | |
-37,08% | 17,95 Md | |
-9,91% | 16,99 Md | |
+7,55% | 14,26 Md | |
+40,04% | 12,76 Md |